-+ 0.00%
-+ 0.00%
-+ 0.00%

On the first day of listing, Tylomaibo rose 246.82% to 50.15 yuan. The issue price of the stock was 14.46 yuan. The main business of Zhuhai Tylomaibo Pharmaceutical Co., Ltd. is the development, production and sale of all-human antibody drugs. The company's main products include stedutamab injections, etc. The company has won awards such as “Specialized, Special and New” Small and Medium Enterprises in Guangdong Province, Guangdong All-Human Monoclonal Antibody Drug Engineering Technology Research Center, High-tech Enterprise, and Guangdong PhD Workstation.

Zhitongcaijing·07/21/2026 01:33:03
Listen to the news
On the first day of listing, Tylomaibo rose 246.82% to 50.15 yuan. The issue price of the stock was 14.46 yuan. The main business of Zhuhai Tylomaibo Pharmaceutical Co., Ltd. is the development, production and sale of all-human antibody drugs. The company's main products include stedutamab injections, etc. The company has won awards such as “Specialized, Special and New” Small and Medium Enterprises in Guangdong Province, Guangdong All-Human Monoclonal Antibody Drug Engineering Technology Research Center, High-tech Enterprise, and Guangdong PhD Workstation.